Measuring quality of diabetes care by linking health care system administrative databases with laboratory data

BMC Research Notes

Table 5 Use of Lipid Lowering Drugs among Diabetic OSK With LDL-C >= 2.5 MMOL/L by Demographic Characteristics

	Persons with LDL-C ≥ 2.5 mmol/L†	Persons dispensed a lipid lowering drug	Crude rate (%)	OR (95% CI)
TOTAL	6914	2711	39.2
AGE (years) Female
20-39	165	31	18.8	0.38 (0.26-0.58)
40-49	389	123	31.6	0.77 (0.60-0.98)
50-59	723	305	42.2	1.21 (1.00-1.46)
60-69	795	329	41.4	1.17 (0.97-1.41)
≥ 70*	1157	435	37.6
AGE (years) Male
20-39	152	41	27.0	0.72 (0.50-1.06)
40-49	428	174	40.7	1.34 (1.07-1.69)
50-59	978	442	45.2	1.61 (1.35-1.93)
60-69	1003	451	45.0	1.60 (1.34-1.91)
≥ 70*	1124	380	33.8
LOCATION
urban*	6196	2416	39.0
non-urban	704	288	40.9	1.09 (0.9-1.3)
INCOME QUINTILE
lowest	1544	569	36.9	0.92 (0.79-1.08)
second	1566	606	38.7	0.97 (0.83-1.13)
third	1320	515	39.0	0.96 (0.82-1.13)
fourth	1267	525	41.4	1.05 (0.90-1.24)
highest*	1191	482	40.5

*Reference category
Drug prescribing data was not available for FN, hence, analysis for lipid lowering prescribing indicators was limited to OSK
Data are stratified by sex because age-sex interaction was present
† Sub-group of prevalent diabetes cases aged 20 years and older at beginning of fiscal year 2005/06 in Saskatchewan's two largest Health Regions

ISSN: 1756-0500